{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:19:23Z","timestamp":1781648363914,"version":"3.54.5"},"reference-count":80,"publisher":"Informa UK Limited","issue":"5","funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Ageing","doi-asserted-by":"crossref","award":["T32 AG076407"],"award-info":[{"award-number":["T32 AG076407"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Therapeutic Patents"],"published-print":{"date-parts":[[2025,5,4]]},"DOI":"10.1080\/13543776.2025.2467679","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T04:36:41Z","timestamp":1739507801000},"page":"463-475","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Update on mGlu4 modulator patents: 2017 to present"],"prefix":"10.1080","volume":"35","author":[{"given":"Fahad Imtiaz","family":"Rahman","sequence":"first","affiliation":[{"name":"University of Nebraska Medical Center","place":["Omaha, USA"]},{"name":"University of Nebraska Medical Center","place":["Omaha, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Webster","sequence":"additional","affiliation":[{"name":"University of Nebraska Medical Center","place":["Omaha, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4958-1697","authenticated-orcid":false,"given":"Corey R.","family":"Hopkins","sequence":"additional","affiliation":[{"name":"University of Nebraska Medical Center","place":["Omaha, USA"]},{"name":"University of Nebraska Medical Center","place":["Omaha, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,2,22]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(99)00092-1"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.37.1.205"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4757-2298-7"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(94)00149-M"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2020.07.008"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2148-9-67"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2012.04.013"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.3c01811"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.4155\/fmc.09.38"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1835724100"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.23-18-07218.2003"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrn1763"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2005.09.006"},{"key":"e_1_3_4_16_1","volume-title":"An essay on the shaking palsy","author":"Parkinson J","year":"1817","unstructured":"Parkinson J. An essay on the shaking palsy. London, Sherwood, Neely and Jones: Kessinger; 1817."},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.318.7179.311"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.10487"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2008.10.005"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2760"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1124\/pr.54.2.323"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2760"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1124\/pr.111.005678"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.12751"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-014-1176-4"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s43440-024-00651-z"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.5772\/19802"},{"issue":"1","key":"e_1_3_4_28_1","first-page":"Abstract 173","article-title":"mGlu4 receptor potentiation for the treatment of Parkinson\u2019s disease","volume":"9","author":"Uberti MA","year":"2011","unstructured":"Uberti MA, Bacolod MD, Jimenez HN, et al. mGlu4 receptor potentiation for the treatment of Parkinson\u2019s disease. Curr Neuropharm. 2011;9 S1(S1):Abstract 173.","journal-title":"Curr Neuropharm"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2008.10.006"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(03)00271-5"},{"issue":"10","key":"e_1_3_4_31_1","first-page":"949","article-title":"Recent progress in the development of mGlur4 positive allosteric modulators for the treatment of Parkinson\u2019s disease","volume":"9","author":"Lindsley CW","year":"2009","unstructured":"Lindsley CW, Niswender CM, Engers DW, et al. Recent progress in the development of mGlur4 positive allosteric modulators for the treatment of Parkinson\u2019s disease. Curr Top Med Chem. 2009;9(10):949\u2013963.","journal-title":"Curr Top Med Chem"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1595-06.2006"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.108.049551"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2012.03.022"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm101271s"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm200956q"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.6b00035"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.6b00036"},{"issue":"1","key":"e_1_3_4_39_1","first-page":"Abstract 22","article-title":"Novel metabotropic glutamate receptor 4 (mGlur4) allosteric potentiators for the treatment of Parkinson\u2019s disease and anxiety","volume":"9","author":"Campo B","year":"2011","unstructured":"Campo B. Novel metabotropic glutamate receptor 4 (mGlur4) allosteric potentiators for the treatment of Parkinson\u2019s disease and anxiety. Curr Neuropharm. 2011;9 S1(S1):Abstract 22.","journal-title":"Curr Neuropharm"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.114.214437"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2010.06.078"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2021.108687"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2019.00020"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2004.07.001"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.112.200915"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2019.00049"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1124\/molpharm.121.000460"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.12254"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-017-0293-z"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1221-13.2013"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106602"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1113\/expphysiol.2012.069922"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells11162608"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.379018"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2007.10.004"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.12608"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2014.00462"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-020-00927-x"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12868-021-00627-2"},{"key":"e_1_3_4_60_1","unstructured":"Charvin D Conquet F. Brain penetrant chromone oxime derivative for the therapy of levodopa-induced dyskinesia. 2017."},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.7b00991"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28970"},{"key":"e_1_3_4_63_1","unstructured":"Biemans B Guba W Jaeschke G et al. Ethynyl derivatives as metabotropic glutamate receptor modulators. 2017."},{"key":"e_1_3_4_64_1","unstructured":"Jaeschke G O\u2019Hara F Plancher J-M et al. Ethynyl derivatives. 2017."},{"key":"e_1_3_4_65_1","unstructured":"Biemans B Jaeschke G Ricci A et al. Ethynyl derivatives. 2018."},{"key":"e_1_3_4_66_1","unstructured":"Jaeschke G O\u2019Hara F Vieira E. Imidazo[1 2-A]imidazol-2-one derivatives for the treatment of diseases such as Parkinson\u2019s disease. 2019."},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1021\/cn9000318"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm9005065"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.8b00426"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2018.10.050"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2018.06.034"},{"key":"e_1_3_4_72_1","unstructured":"Conn PJ Lindsley CW Felts A et al. Indazole compounds as mGlur4 allosteric potentiators compositions and methods of treating neurological disorders. 2019."},{"key":"e_1_3_4_73_1","unstructured":"Conn PJ Lindsley CW Felts A. Benzomorpholine and benzomorpholine-substituted compounds as mGlur4 allosteric potentiators compositions and methods of treating neurological dysfunction. 2019."},{"key":"e_1_3_4_74_1","unstructured":"Conn PJ Lindsley CW Felts A et al. Pyridine quinoline compounds as mGlur4 allosteric potentiators compositions and methods of treating neurological dysfunction. 2019."},{"key":"e_1_3_4_75_1","unstructured":"Conn PJ Lindsley CW Hopkins CR et al. Isoquinoline amide and isoquinoline amide-substituted compounds as mGlur4 allosteric potentiators compositions and methods of treating neurological dysfunction. 2020."},{"key":"e_1_3_4_76_1","unstructured":"Conn PJ Lindsley CW Felts A et al. Isoquinoline ether compounds as mGlur4 allosteric potentiators compositions and methods of treating neurological dysfunction. 2021."},{"key":"e_1_3_4_77_1","unstructured":"Conn PJ Lindsley CW Felts A. Isoquinoline amine compounds as mGlur4 allosteric potentiators compositions and methods of treating neurological dysfunction. 2022."},{"key":"e_1_3_4_78_1","unstructured":"Amalric C Barre A Schann S et al. Substituted quinazoline derivatives and their use as positive allosteric modulators of mGlur4. 2020."},{"key":"e_1_3_4_79_1","unstructured":"Pilc A Bojarski AJ Stankiewicz A et al. 1 2 4-oxadiazole derivatives as allosteric modulators of metabotropic glutamate receptors belonging to group III. 2020."},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.1080\/14756366.2021.1998022"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(03)01326-8"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130050125"}],"container-title":["Expert Opinion on Therapeutic Patents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543776.2025.2467679","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T11:16:23Z","timestamp":1746184583000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543776.2025.2467679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,22]]},"references-count":80,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5,4]]}},"alternative-id":["10.1080\/13543776.2025.2467679"],"URL":"https:\/\/doi.org\/10.1080\/13543776.2025.2467679","relation":{},"ISSN":["1354-3776","1744-7674"],"issn-type":[{"value":"1354-3776","type":"print"},{"value":"1744-7674","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,22]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-10-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}